Filing Details
- Accession Number:
- 0000899243-20-025576
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-09-17 18:35:05
- Reporting Period:
- 2020-09-15
- Accepted Time:
- 2020-09-17 18:35:05
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1711279 | Krystal Biotech Inc. | KRYS | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1298711 | Suma Krishnan | C/O Krystal Biotech, Inc. 2100 Wharton Street, Suite 701 Pittsburgh PA 15203 | Chief Operating Officer | Yes | Yes | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2020-09-15 | 14,435 | $46.21 | 1,871,629 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-09-15 | 1,517 | $47.15 | 1,870,112 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-09-16 | 9,749 | $46.24 | 1,860,363 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-09-16 | 5,142 | $46.85 | 1,855,221 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-09-17 | 10,594 | $46.09 | 1,844,627 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-09-17 | 7,437 | $46.63 | 1,837,190 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-09-17 | 1,126 | $47.29 | 1,836,064 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 112,162 | Indirect | By Trust |
| Common Stock | 1,886,462 | Indirect | By Spouse |
Footnotes
- The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person following discussions with the Compensation Committee and the Board of Directors. The Rule 10b5-1 trading plan has now expired.
- This transaction was executed in multiple trades ranging from $45.76 to $46.75. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
- This transaction was executed in multiple trades ranging from $46.76 to $47.66. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
- This transaction was executed in multiple trades ranging from $45.64 to $46.62. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
- This transaction was executed in multiple trades ranging from $46.64 to $47.14. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
- This transaction was executed in multiple trades ranging from $45.27 to $46.26. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
- This transaction was executed in multiple trades ranging from $46.27 to $47.24. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
- This transaction was executed in multiple trades ranging from $47.27 to $47.34. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
- Directly beneficially owned by the Krishnan Family Trust. The reporting person and her spouse are each joint beneficial owners of the trust with joint voting and investment control.
- Directly beneficially owned by Krish S. Krishnan, the spouse of the reporting person.
Billionaire Hedge Funds
